/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/2024-09-09-16-56-46-041-66df28ce097b7a1aca18cbd0.jpg)
Regulatory AIFA updates Guidelines for the classification and conduct of observational studies on medicines On 20 August 2024, the...
Cortex - Life Sciences Insights
As of March 28, The Italian Council of Ministers have approved the new Public Contracts Code. The Legislative Decree No. 36 of March 31,...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2022-09-20-16-13-41-993-6329e6b5f636e90f2482b0c4.jpg)
Italy enacted legislation to adapt the national framework governing medical devices and in vitro-diagnostic medical devices to the MDR...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2021-11-25-10-47-06-757-619f69aa49b2040aec3eb165.jpg)
With Circular 0081386 dated 12 November 2021, the Italian Ministry of Health confirmed that the national pre-authorization requirements...
On 1 January 2021, important transparency obligations provided for in the Code of Ethics of Confindustria Dispositivi Medici (the Italian...
Between 9 and 11 April I will be in Basilea with Johan Renes from DLA Piper Amsterdam and Paula Gonzalez from DLA Piper Madrid at the...
Really looking forward to meeting you at the IP Forum for Life Sciences in April. I will be hosting a discussion with tregard to naming...
The m-Health market will reach approx. $ 26 billion globally by 2017 with a number of m-Health apps downloaded worldwide of about 3.2...
For the first time, in Eli Lilly v Actavis the UK Supreme Court has introduced a doctrine of equivalence in an effort to move closer to...
In the near future the European Medicines Agency (EMA), the agency responsible for the scientific evaluation, supervision and safety...
